These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27340107)

  • 1. Gene Expression Profiling of Breast Cancer Brain Metastasis.
    Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
    Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
    Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
    Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
    Zhang L; Wang L; Yang H; Li C; Fang C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of breast cancer CTCs associated with brain metastasis.
    Boral D; Vishnoi M; Liu HN; Yin W; Sprouse ML; Scamardo A; Hong DS; Tan TZ; Thiery JP; Chang JC; Marchetti D
    Nat Commun; 2017 Aug; 8(1):196. PubMed ID: 28775303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
    Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
    BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific gene expression signature for visceral organ metastasis in breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
    BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.
    Giannoudis A; Clarke K; Zakaria R; Varešlija D; Farahani M; Rainbow L; Platt-Higgins A; Ruthven S; Brougham KA; Rudland PS; Jenkinson MD; Young LS; Falciani F; Palmieri C
    Sci Rep; 2019 Dec; 9(1):18518. PubMed ID: 31811234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
    Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
    Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
    PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
    Lluch A; González-Angulo AM; Casadevall D; Eterovic AK; Martínez de Dueñas E; Zheng X; Guerrero-Zotano Á; Liu S; Pérez R; Chen K; Chacón JI; Mills GB; Antolín S; Blancas I; López-Serra P; Carrasco E; Caballero R; Prat A; Rojo F; Gonzalez-Perez A; Meric-Bernstam F; Albanell J
    Eur J Cancer; 2019 Oct; 120():54-64. PubMed ID: 31491604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
    Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
    Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival.
    Giannoudis A; Sartori A; Eastoe L; Zakaria R; Charlton C; Hickson N; Platt-Higgins A; Rudland PS; Irwin D; Jenkinson MD; Palmieri C
    Breast Cancer Res Treat; 2021 Nov; 190(2):241-253. PubMed ID: 34499316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
    Varešlija D; Priedigkeit N; Fagan A; Purcell S; Cosgrove N; O'Halloran PJ; Ward E; Cocchiglia S; Hartmaier R; Castro CA; Zhu L; Tseng GC; Lucas PC; Puhalla SL; Brufsky AM; Hamilton RL; Mathew A; Leone JP; Basudan A; Hudson L; Dwyer R; Das S; O'Connor DP; Buckley PG; Farrell M; Hill ADK; Oesterreich S; Lee AV; Young LS
    J Natl Cancer Inst; 2019 Apr; 111(4):388-398. PubMed ID: 29961873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
    Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
    Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Related Clusters and Favorable Immune Phenotypes in Young Breast Cancer Patients.
    Ingebriktsen LM; Svanøe AA; Myrmel Sæle AK; Humlevik ROC; Toska K; Kalvenes MB; Aas T; Heie A; Askeland C; Knutsvik G; Stefansson IM; Akslen LA; Hoivik EA; Wik E
    Mod Pathol; 2024 Aug; 37(8):100529. PubMed ID: 38810731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy.
    Noh MG; Kim SS; Kim YJ; Jung TY; Jung S; Rhee JH; Lee JH; Lee JS; Cho JH; Moon KS; Park H; Lee KH
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter.
    Chen YJ; Huang CS; Phan NN; Lu TP; Liu CY; Huang CJ; Chiu JH; Tseng LM; Huang CC
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34387660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.